Chris Turley and Clare Harman Clark write for PropertyEU on 'COVID-19' clauses in leases
As the world adjusts to the impact of coronavirus, the real estate sector is focusing on preventative measures that will protect their interests in the future, and from future pandemics.
Ross McNaughton joins Taylor Wessing as a new partner hire
Taylor Wessing is pleased to announce the appointment of Ross McNaughton as partner in its corporate technology team, based in Cambridge. Ross joins the firm on 1 July.
Coping with redundancy
Redundancy occurs when an employee is dismissed due to the closure or intended closure of a business or when there is a reduction in the workforce. COVID-19 has caused a huge increase in the numbers of redundancies companies are making across the UK.
Keeping employees motivated through tough times
From showing employee appreciation to nurturing skills, there are plenty of cost-effective ways to motivate your staff at a time like this. The HR Dept suggests a few to get you started...
EnfuseNet: Rewriting the economics of vehicle autonomy
Cambridge Consultants has developed EnfuseNet, a breakthrough Artificial Intelligence (AI) system for autonomous vehicles - a low-cost system that generates high-resolution depth data for vehicle perception technology.
Xaar celebrates 30 years as an industrial inkjet innovator
Xaar is celebrating its 30th birthday in style with champagne sent to every member of the team to toast the business and its role in pioneering the use of industrial inkjet technologies around the world.
Preliminary trial results find antiviral drug lopinavir/ritonavir does not reduce death in hospitalised patients with COVID-19
The ‘RECOVERY’ trial has released preliminary results showing lopinavir/ritonavir, an antiviral drug commonly used to treat HIV, had no significant mortality benefit in hospitalised COVID-19 patients.
De-risking drug innovation: biotech vs big pharma
Most approved “priority” medicines are developed by biotech rather than large pharmaceutical firms, says a two-decade study at the University of Cambridge Judge Business School.
BioStrata further strengthens specialist life science marketing team with new hires
BioStrata, the life science marketing specialist, has appointed two new recruits further advancing the agency’s expert marketing team.
Playtime with dad may improve children’s self-control
Children whose fathers make time to play with them from a very young age may find it easier to control their behaviour and emotions as they grow up, research suggests.
Announcing the Cambridge Folk Festival at Home 2020
The Cambridge Folk Festival at Home 2020 will be a celebration of all things Cambridge that you can enjoy from your garden or living room.
Further £191m support package unveiled to help innovative businesses bounce back from COVID-19 impact
Innovate UK, part of UK Research and Innovation, has launched a new fund to help cutting-edge companies of all sizes recover, grow, and drive a re-building economy.
Swiss Life REIM (France) entrusts Taylor Wessing with Hamburg office building disposal for EUR 150m
Taylor Wessing has advised Swiss Life REIM (France) on the disposal of “Neuer Dovenhof” in Hamburg to Zurich. The net purchase price amounts to approximately EUR 150 million.
Cambridge spin-out PharmEnable raises £1.8m for drug discovery expansion
PharmEnable, a Cambridge-based drug discovery company using advanced medicinal chemistry and AI-enabled approaches to design the next generation of highly complex and specific drug candidate molecules, announces it has closed a £1.8 million seed financing to support its transition into a drug development company.
Times of crisis call for more than an updated CV!
It’s hard for any of us to ignore that the world is in the grips of a crisis. It is in times like this of mass uncertainty and economic instability that many Cambridge companies have to make difficult decisions, often leading to redundancies.
CMR Surgical reports strong progress
CMR Surgical Ltd, the company behind the next-generation surgical robotic system Versius®, today announces a mid-year business update.
Science, policy and pandemics: Vaccines
What do we know about covid-19 vaccine candidates under development? What is involved in the vaccine development, trial and innovation process? How will a successful vaccine be distributed?
Council works to get city back on its feet despite financial challenges
As Cambridge City Council works to support the recovery of the city after the impact of Covid-19, a report on council finances suggests the impact on the council could add up to losses of £10m in the current year.
CPFT joins national research network to improve mental health care
People using mental health services, including children and young people across the country, are set to benefit from a new national research network leading projects to improve practice and care.
New artificial heart valve could transform open-heart surgery
A new type of artificial heart valve, made of long-lived polymers, could mean that millions of patients with diseased heart valves will no longer require lifelong blood-thinning medication after valve replacement surgery.
How do AI, video conferencing and other technologies affect the workplace?
The latest podcast from Cambridge Judge Business School focuses on technology at work at a time when many people are working at home. The podcast, which was recorded remotely, looks at the roles of artificial intelligence (AI), machine learning and other automation, and their short- and long-term effects on the workplace and skills development.
Cambridge Index falls 0.8%
The Cambridge Index dropped 190.7 points or 0.8% to close at 23,169.0, as eight of the top ten Index heavyweights posted weekly losses to their share price.
AWS Cloud IoT projects advanced by Cambridge team
Cambridge-based professional services consultancy Green Custard joins an elite group of just 35 companies to achieve AWS CloudFormation Service Delivery Partner status. This award-winning company drives value through creative software solutions and this new AWS CloudFormation Delivery Partner status is recognition of their expertise by the architects at Amazon Web Services. It is Amazon's highest…
Extensions to planning permissions expiring during pandemic
In response to the development sector, the Government has published the Business and Planning Bill to extend planning permissions and listed building consents until 1 April 2021. Gemma Dudley of Hewitsons provides the details.
Birketts advises tech recruitment heavyweight on management buy-out
Birketts has advised high-tech recruitment expert firm ECM Selection on the successful management buy-out by the new directors, Mr Dan Archer and Dr Keith Tan.